Validation of a rabbit model of neuropathy induced by immunization with gangliosides

Journal of the Neurological Sciences

Volumn 272, Issue 1-2, 2008, Pages 110-114

  Moyano, A L ^a   Comin R ^a   Lardone, R D ^a   Alaniz, M E ^a   Theaux, R ^b   Irazoqui, F J ^a   Nores, G A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Anti GM1 antibodies; Experimental neuropathy; Ganglioside; Guillain Barr ; syndrome

Indexed keywords

BRAIN GANGLIOSIDE; GANGLIOSIDE; GANGLIOSIDE GM1; KEYHOLE LIMPET HEMOCYANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GUILLAIN BARRE SYNDROME; IMMUNIZATION; LABORATORY; MALE; NEUROLOGIC DISEASE; NEUROPATHY; NONHUMAN; OPERATOR; PRIORITY JOURNAL; RABBIT; TIME; VALIDATION STUDY;

ANIMALS; DISEASE MODELS, ANIMAL; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; IMMUNIZATION; MALE; PERIPHERAL NERVES; RABBITS; TIME FACTORS;

EID: 48349128705     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.05.006     Document Type: Article

References (23)

1. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
2. Sadiq S.A., Thomas F.P., Kilidireas K., Protopsaltis S., Hays A.P., Lee K.W., et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 40 (1990) 1067-1072
3. Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs. 64 (2004) 597-610
4. Nagai Y., Momoi T., Saito M., Mitsuzawa E., and Ohtani S. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2 (1976) 107-111
5. Panzetta P., Gravotta D., and Maccioni H.J. Biosynthesis and expression of gangliosides during differentiation of chick embryo retina cells in vitro. J Neurochem 49 (1987) 1763-1771
6. Thomas F.P., Trojaborg W., Nagy C., Santoro M., Sadiq S.A., Latov N., et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 82 (1991) 378-383
7. Lopez P.H., Villa A.M., Sica R.E., and Nores G.A. High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies. J Neuroimmunol 128 (2002) 69-76
8. Kusunoki S., Shimizu J., Chiba A., Ugawa Y., Hitoshi S., and Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39 (1996) 424-431
9. Yuki N., Yamada M., Koga M., Odaka M., Susuki K., Tagawa Y., et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 (2001) 712-720
10. Dasgupta S., Li D., and Yu R.K. Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides. Neurochem Res 29 (2004) 2147-2152
11. Comín R., Lopez P.H.H., Yuki N., and Nores G.A. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy. J Neurosci Res 84 (2006) 1085-1090
12. Cumar F.A., Barra H.S., Maccioni H.J., and Caputto R. Sulfation of glycosphingolipids and related carbohydrates by brain preparations from young rats. J Biol Chem 243 (1968) 3807-3816
13. Folch-Pi J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
14. Yu R.K., and Ledeen R.W. Gangliosides of human, bovine, and rabbit plasma. J Lipid Res 13 (1972) 680-686
15. Williams M.A., and McCluer R.H. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 35 (1980) 266-269
16. Mizutamari R.K., Wiegandt H., and Nores G.A. Characterization of anti-ganglioside antibodies present in normal human plasma. J Neuroimmunol 50 (1994) 215-220
17. Kusunoki S., Shiina M., and Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 57 (2001) 736-738
18. Dabby R., Weimer L.H., Hays A.P., Olarte M., and Latov N. Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology 54 (2000) 1448-1452
19. Susuki K., Nishimoto Y., Yamada M., Baba M., Ueda S., Hirata K., et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54 (2003) 383-388
20. Susuki K., Nishimoto Y., Koga M., Nagashima T., Mori I., Hirata K., and Yuki N. Various immunization protocols for an acute motor axonal neuropathy rabbit model compared. Neurosci Lett 368 (2004) 63-67
21. Nachamkin I. Rabbit model of Guillain-Barre syndrome. Ann Neurol 52 (2002) 127-128
22. Lopez P.H., Lardone R.D., Irazoqui F.J., Maccioni M., and Nores G.A. The origin of anti-GM1 antibodies in neuropathies: the "binding site drift" hypothesis. Neurochem Res 27 (2002) 687-695
23. Lopez P.H., Lardone R.D., Irazo qui F.J., Villa A.M., Di E.M., Saizar R.D., et al. Variable patterns of anti-GM(1) IgM-antibody populations defined by affinity and fine specificity in patients with motor syndromes: evidence for their random origin. J Neuroimmunol 119 (2001) 131-136